SOLMIRA Trademark

Trademark Overview

On Thursday, March 28, 2002, a trademark application was filed for SOLMIRA with the United States Patent and Trademark Office. The USPTO has given the SOLMIRA trademark a serial number of 76389464. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, April 16, 2006. This trademark is owned by GENENTECH, INC.. The SOLMIRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in the treatment of immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, and inflammatory diseases and disorders
solmira

General Information

Serial Number76389464
Word MarkSOLMIRA
Filing DateThursday, March 28, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, April 16, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 21, 2003

Trademark Statements

Goods and ServicesPharmaceuticals for use in the treatment of immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, and inflammatory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 9, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENENTECH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990
Party NameGENENTECH, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990

Trademark Events

Event DateEvent Description
Tuesday, June 20, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, June 20, 2006ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 21, 2005EXTENSION 5 GRANTED
Wednesday, September 21, 2005EXTENSION 5 FILED
Wednesday, September 21, 2005TEAS EXTENSION RECEIVED
Monday, April 18, 2005EXTENSION 4 GRANTED
Wednesday, March 23, 2005EXTENSION 4 FILED
Wednesday, March 23, 2005TEAS EXTENSION RECEIVED
Friday, February 18, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 24, 2004EXTENSION 3 GRANTED
Friday, October 15, 2004EXTENSION 3 FILED
Tuesday, November 2, 2004EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, November 2, 2004PETITION TO REVIVE-GRANTED
Tuesday, November 2, 2004TEAS PETITION TO REVIVE RECEIVED
Monday, July 5, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 7, 2004EXTENSION 2 GRANTED
Tuesday, March 30, 2004EXTENSION 2 FILED
Monday, April 5, 2004CASE FILE IN TICRS
Tuesday, March 30, 2004TEAS EXTENSION RECEIVED
Friday, November 14, 2003EXTENSION 1 GRANTED
Tuesday, October 14, 2003EXTENSION 1 FILED
Monday, October 20, 2003PAPER RECEIVED
Wednesday, April 23, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 15, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2003PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2003NOTICE OF PUBLICATION
Friday, November 15, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 7, 2002EXAMINERS AMENDMENT MAILED
Monday, October 7, 2002PAPER RECEIVED
Friday, September 27, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 27, 2002PAPER RECEIVED
Friday, August 2, 2002NON-FINAL ACTION MAILED
Friday, July 26, 2002ASSIGNED TO EXAMINER

Related Keywords

solmira disorders diseases ocular inflammatory angiogenesis treatment pharmaceuticals immune